Cellectar Biosciences Current Ratio 2012-2025 | CLRB
Cellectar Biosciences current ratio from 2012 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Cellectar Biosciences Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-09-30 | $0.01B | $0.01B | 2.77 |
| 2025-06-30 | $0.01B | $0.01B | 2.15 |
| 2025-03-31 | $0.02B | $0.01B | 2.47 |
| 2024-12-31 | $0.02B | $0.01B | 2.58 |
| 2024-09-30 | $0.04B | $0.02B | 1.77 |
| 2024-06-30 | $0.03B | $0.02B | 1.84 |
| 2024-03-31 | $0.04B | $0.03B | 1.45 |
| 2023-12-31 | $0.01B | $0.03B | 0.41 |
| 2023-09-30 | $0.02B | $0.02B | 1.22 |
| 2023-06-30 | $0.01B | $0.01B | 0.87 |
| 2023-03-31 | $0.01B | $0.01B | 1.99 |
| 2022-12-31 | $0.02B | $0.01B | 1.79 |
| 2022-09-30 | $0.02B | $0.01B | 2.88 |
| 2022-06-30 | $0.03B | $0.01B | 4.51 |
| 2022-03-31 | $0.03B | $0.01B | 6.75 |
| 2021-12-31 | $0.04B | $0.00B | 9.17 |
| 2021-09-30 | $0.04B | $0.00B | 13.08 |
| 2021-06-30 | $0.05B | $0.00B | 13.39 |
| 2021-03-31 | $0.05B | $0.01B | 10.84 |
| 2020-12-31 | $0.06B | $0.00B | 16.26 |
| 2020-09-30 | $0.02B | $0.00B | 5.01 |
| 2020-06-30 | $0.02B | $0.00B | 6.94 |
| 2020-03-31 | $0.01B | $0.00B | 2.58 |
| 2019-12-31 | $0.01B | $0.00B | 4.11 |
| 2019-09-30 | $0.02B | $0.00B | 4.95 |
| 2019-06-30 | $0.02B | $0.00B | 6.80 |
| 2019-03-31 | $0.01B | $0.00B | 5.04 |
| 2018-12-31 | $0.01B | $0.00B | 8.60 |
| 2018-09-30 | $0.02B | $0.00B | 6.43 |
| 2018-06-30 | $0.01B | $0.00B | 2.19 |
| 2018-03-31 | $0.01B | $0.00B | 3.63 |
| 2017-12-31 | $0.01B | $0.00B | 4.95 |
| 2017-09-30 | $0.01B | $0.00B | 3.14 |
| 2017-06-30 | $0.01B | $0.00B | 5.88 |
| 2017-03-31 | $0.01B | $0.00B | 8.71 |
| 2016-12-31 | $0.01B | $0.00B | 7.47 |
| 2016-09-30 | $0.01B | $0.00B | 4.31 |
| 2016-06-30 | $0.01B | $0.00B | 5.84 |
| 2016-03-31 | $0.00B | $0.00B | 0.80 |
| 2015-12-31 | $0.00B | $0.01B | 0.73 |
| 2015-09-30 | $0.00B | $0.01B | 0.54 |
| 2015-06-30 | $0.01B | $0.01B | 0.86 |
| 2015-03-31 | $0.01B | $0.01B | 1.23 |
| 2014-12-31 | $0.01B | $0.01B | 1.56 |
| 2014-09-30 | $0.01B | $0.00B | 5.77 |
| 2014-06-30 | $0.00B | $0.00B | 0.49 |
| 2014-03-31 | $0.00B | $0.00B | 0.93 |
| 2013-12-31 | $0.00B | $0.01B | 0.61 |
| 2013-09-30 | $0.01B | $0.01B | 1.19 |
| 2013-06-30 | $0.01B | $0.01B | 0.99 |
| 2013-03-31 | $0.01B | $0.01B | 1.23 |
| 2012-12-31 | $0.01B | $0.00B | 7.00 |
| 2012-09-30 | $0.01B | $0.00B | 8.13 |
| 2012-06-30 | $0.01B | $0.00B | 11.55 |
| 2012-03-31 | $0.00B | $0.00B | 7.95 |
| 2011-12-31 | $0.01B | $0.00B | 11.55 |
| 2011-09-30 | $0.00B | $0.00B | 4.04 |
| 2011-06-30 | $0.00B | $0.00B | 7.74 |
| 2011-03-31 | $0.00B | $0.00B | 2.44 |
| 2010-12-31 | $0.00B | $0.00B | 1.41 |
| 2010-09-30 | $0.00B | $0.01B | 0.54 |
| 2010-06-30 | $0.00B | $0.01B | 0.64 |
| 2010-03-31 | $0.01B | $0.01B | 0.98 |
| 2009-12-31 | $0.01B | $0.02B | 0.52 |
| 2009-09-30 | $0.01B | $0.01B | 0.80 |
| 2009-06-30 | $0.01B | $0.01B | 0.58 |
| 2009-03-31 | $0.01B | $0.01B | 1.43 |
| 2008-12-31 | $0.00B | $0.01B | 0.21 |
| 2008-09-30 | $0.00B | $0.01B | 0.63 |
| 2008-06-30 | $0.01B | $0.01B | 0.69 |
| 2008-03-31 | $0.01B | $0.01B | 0.69 |
| 2007-12-31 | $0.01B | $0.01B | 1.57 |
| 2007-09-30 | $0.02B | $0.01B | 3.29 |
| 2007-06-30 | $0.02B | $0.00B | 7.04 |
| 2007-03-31 | $0.01B | $0.00B | 7.38 |
| 2006-12-31 | $0.01B | $0.00B | 9.07 |
| 2006-09-30 | $0.01B | $0.00B | 12.99 |
| 2006-06-30 | $0.02B | $0.00B | 26.29 |
| 2006-03-31 | $0.02B | $0.00B | 37.92 |
| 2005-12-31 | $0.01B | $0.00B | 22.86 |
| 2005-09-30 | $0.01B | $0.00B | 8.19 |
| 2005-06-30 | $0.00B | $0.00B | 2.35 |
| 2005-03-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.016B | $0.000B |
| Cellectar Biosciences, Inc. is developing agents to detect, treat and monitor a broad spectrum of cancers. It uses a novel phospholipid ether platform technology as a targeted delivery and retention vehicle. Cellectar Biosciences Inc., formerly known as Novelos Therapeutics, Inc., is headquartered in Madison, Wisconsin. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $217.359B | 25.05 |
| EssilorLuxottica (ESLOY) | France | $151.069B | 0.00 |
| Boston Scientific (BSX) | United States | $138.964B | 31.78 |
| Stryker (SYK) | United States | $137.439B | 27.29 |
| Medtronic (MDT) | Ireland | $126.586B | 17.54 |
| Medline (MDLN) | United States | $57.028B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.992B | 0.00 |
| Agilent Technologies (A) | United States | $41.368B | 26.15 |
| GE HealthCare Technologies (GEHC) | United States | $38.856B | 18.58 |
| ResMed (RMD) | United States | $37.873B | 26.21 |
| Koninklijke Philips (PHG) | Netherlands | $28.984B | 18.93 |
| Terumo (TRUMY) | Japan | $21.172B | 23.83 |
| Insulet (PODD) | United States | $19.900B | 61.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.686B | 11.03 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.986B | 0.00 |
| Baxter (BAX) | United States | $10.199B | 8.23 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.585B | 30.87 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.350B | 13.25 |
| BillionToOne (BLLN) | United States | $4.319B | 0.00 |
| Envista Holdings (NVST) | United States | $3.979B | 22.83 |
| ICU Medical (ICUI) | United States | $3.666B | 23.28 |
| Haemonetics (HAE) | United States | $3.545B | 15.78 |
| Prestige Consumer Healthcare (PBH) | United States | $3.115B | 14.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.333B | 15.00 |
| Perrigo (PRGO) | Ireland | $2.045B | 5.12 |
| Neogen (NEOG) | United States | $2.043B | 44.71 |
| LeMaitre Vascular (LMAT) | United States | $1.939B | 39.02 |
| Curaleaf Holdings (CURLF) | Canada | $1.866B | 0.00 |
| AtriCure (ATRC) | United States | $1.858B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.734B | 76.00 |
| Phibro Animal Health (PAHC) | United States | $1.616B | 16.14 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.471B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.427B | 20.67 |
| Kestra Medical Technologies (KMTS) | United States | $1.302B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.170B | 347.00 |
| Capricor Therapeutics (CAPR) | United States | $1.133B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.112B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.007B | 0.00 |
| Omeros (OMER) | United States | $0.927B | 0.00 |
| Valneva SE (VALN) | France | $0.893B | 0.00 |
| InMode (INMD) | Israel | $0.887B | 10.03 |
| CeriBell (CBLL) | United States | $0.851B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.573B | 15.55 |
| Cerus (CERS) | United States | $0.526B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.483B | 0.00 |
| Brainsway (BWAY) | Israel | $0.461B | 78.50 |
| Canopy Growth (CGC) | Canada | $0.450B | 0.00 |
| SNDL (SNDL) | Canada | $0.428B | 0.00 |
| Quanterix (QTRX) | United States | $0.343B | 0.00 |
| Evolus (EOLS) | United States | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 22.06 |
| TerrAscend (TSNDF) | Canada | $0.243B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.241B | 142.00 |
| Sanuwave Health (SNWV) | United States | $0.241B | 0.00 |
| High Tide (HITI) | Canada | $0.228B | 0.00 |
| Organigram Global (OGI) | Canada | $0.218B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanara MedTech (SMTI) | United States | $0.206B | 0.00 |
| Accendra Health (ACH) | United States | $0.200B | 2.00 |
| Vireo Growth (VREOF) | United States | $0.197B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.193B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.189B | 16.64 |
| Quipt Home Medical (QIPT) | United States | $0.159B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.145B | 0.00 |
| Apyx Medical (APYX) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.143B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.120B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.77 |
| Exagen (XGN) | United States | $0.115B | 0.00 |
| MacroGenics (MGNX) | United States | $0.113B | 0.00 |
| Biote (BTMD) | United States | $0.109B | 4.76 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.46 |
| Nephros (NEPH) | United States | $0.047B | 33.92 |
| Cytosorbents (CTSO) | United States | $0.045B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.74 |
| Jin Medical (ZJYL) | China | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Bonk (BNKK) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |